New pill tested for deadly lung scarring disease
Disease control
Recruiting now
This is the first human study testing a new oral medication called GNS-3545, which is being developed to treat idiopathic pulmonary fibrosis—a serious disease that causes progressive lung scarring. The study will enroll 72 healthy adults to check the drug's safety, how it moves t…
Phase: PHASE1 • Sponsor: Genosco Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC